Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
Enregistré dans:
Auteurs principaux: | Mustafa Erman, Bivas Biswas, Pongwut Danchaivijitr, Lingwu Chen, Yoke Fui Wong, Tarek Hashem, Chun Sen Lim, Bulent Karabulut, Hsiao-Jen Chung, Chandrasekhar Chikatapu, Sara Ingles, Khemaies Slimane, Ravindran Kanesvaran |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c4088abcfc2b4a2295bba6b69afcf827 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pazopanib for the treatment of soft-tissue sarcoma
par: Heudel P, et autres
Publié: (2012) -
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
par: Peter E Clark
Publié: (2010) -
Intra-Tumoral Pharmacokinetics of Pazopanib in Combination with Radiotherapy in Patients with Non-Metastatic Soft-Tissue Sarcoma
par: Laura Molenaar-Kuijsten, et autres
Publié: (2021) -
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
par: Sewanti Limaye, et autres
Publié: (2021) -
Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis.
par: Hisaki Aiba, et autres
Publié: (2021)